CHAD PHILLIPS: Open Payments
NPI 1992190359 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$641 in 28 payments from 13 companies in 2025. Trend: 2023 $863 · 2024 $1,458 · 2025 $641
Food & beverage: $641
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $145 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $85 |
| Lundbeck LLC | 4 | $74 |
| ABBVIE INC. | 4 | $70 |
| Alkermes, Inc. | 3 | $60 |
| Axsome Therapeutics, Inc. | 3 | $57 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $27 |
| Tris Pharma Inc | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: FANAPT, REXULTI, CAPLYTA, VRAYLAR, Auvelity, ARISTADA, HETLIOZ, Dyanavel XR.
Industry payments across TN — which companies pay providers there.
